Web Watch

Share this article:
The online health space is hotter than high school love right now. The people at WebMD must be looking over their shoulder.

 Yahoo! Health and MSN Health are already attracting large audiences of health seekers and their early entry into the online health space has allowed them to establish themselves as a valuable resource for health information.

The HealthCentral Network recently expanded and now publishes 25 targeted media channels under the guidance of president  & CEO Chris Schroeder.

HealthFinder, MedlinePlus and Womenshealth.gov now offer an array of info in English as well as Spanish.

NBC Universal, parent company of iVillage, Healthology, and HealthCentersOnline, launched iVillage Total Health, a site that leverages all of NBC Universal's online and offline media assets which include regular segments on Today Show as well as iVillage live.

Waterfront Media launched Everydayhealth.com a site that offers advice from experts, health news, online check ups and other unique features.

Former AOL founder Steve Case has put together an impressive team to create Revolution Health. The preview site promises smarter health tools, more relevant information and expert support from live professionals. 

WebMD certainly isn't standing pat while all this activity swirls around them. Their acquisitions of Summex, a provider of health and wellness programs, and  Subimo, a company that specializes in healthcare decision support, suggests their strategy includes the emerging corporate wellness market.

Healthcare marketers are the likely benefactors of the health information portal expansion as targeted health ad inventory increases keeping prices at a reasonable level. There are likely to be some sponsorship opportunities as these portals find new ways to engage health info seekers.

Dan McKillen is president of the HealthDay news service

Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...